Biological Effects of Quercetin in COPD Phase II

NCT06003270 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Emphysema
Chronic Bronchitis With Airway Obstruction

Interventions

DRUG: Quercetin 1000 mg
DRUG: Quercetin 500 MG
DRUG: Placebo

Sponsor

Temple University

Collaborators

[object Object]
[object Object]